how does glp-1 affect the brain From metabolism to mind: expanding role of the receptor in neurotherapeutics Cardiovascular, pancreas and brain effects

What are the benefits of drinking diet soda

Cardiometabolic Improvements Weight loss was accompanied by clinically meaningful improvements across several cardiovascular risk markers, including reductions in: Waist circumference (mean reduction of approximately 24.1 cm at the highest dose) Non-HDL cholesterol Triglycerides Systolic blood pressure High-sensitivity C-reactive protein (hsCRP) a marker of inflammation These findings are particularly relevant for patients with obesity who also live with cardiometabolic conditions, where systemic risk reduction is as important as the weight loss itself

G., & Ghassemi, A

doi: 10.2146/ajhp150990 5 HirschIB

GLP-1 receptor agonists: targeting both hyperglycaemia and disease processes in diabetes

Underlying cardiovascular disease: Many patients prescribed GLP-1 medications have cardiovascular risk factors or established heart disease